PMID- 25068019
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20140728
LR  - 20211021
IS  - 1949-8462 (Print)
IS  - 1949-8462 (Electronic)
VI  - 6
IP  - 7
DP  - 2014 Jul 26
TI  - Distribution of late gadolinium enhancement in various types of cardiomyopathies: 
      Significance in differential diagnosis, clinical features and prognosis.
PG  - 585-601
LID - 10.4330/wjc.v6.i7.585 [doi]
AB  - The recent development of cardiac magnetic resonance (CMR) techniques has allowed 
      detailed analyses of cardiac function and tissue characterization with high 
      spatial resolution. We review characteristic CMR features in ischemic and 
      non-ischemic cardiomyopathies (ICM and NICM), especially in terms of the location 
      and distribution of late gadolinium enhancement (LGE). CMR in ICM shows segmental 
      wall motion abnormalities or wall thinning in a particular coronary arterial 
      territory, and the subendocardial or transmural LGE. LGE in NICM generally does 
      not correspond to any particular coronary artery distribution and is located 
      mostly in the mid-wall to subepicardial layer. The analysis of LGE distribution 
      is valuable to differentiate NICM with diffusely impaired systolic function, 
      including dilated cardiomyopathy, end-stage hypertrophic cardiomyopathy (HCM), 
      cardiac sarcoidosis, and myocarditis, and those with diffuse left ventricular 
      (LV) hypertrophy including HCM, cardiac amyloidosis and Anderson-Fabry disease. A 
      transient low signal intensity LGE in regions of severe LV dysfunction is a 
      particular feature of stress cardiomyopathy. In arrhythmogenic right ventricular 
      cardiomyopathy/dysplasia, an enhancement of right ventricular (RV) wall with 
      functional and morphological changes of RV becomes apparent. Finally, the 
      analyses of LGE distribution have potentials to predict cardiac outcomes and 
      response to treatments.
FAU - Satoh, Hiroshi
AU  - Satoh H
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Sano, Makoto
AU  - Sano M
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Suwa, Kenichiro
AU  - Suwa K
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Saitoh, Takeji
AU  - Saitoh T
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Nobuhara, Mamoru
AU  - Nobuhara M
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Saotome, Masao
AU  - Saotome M
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Urushida, Tsuyoshi
AU  - Urushida T
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Katoh, Hideki
AU  - Katoh H
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
FAU - Hayashi, Hideharu
AU  - Hayashi H
AD  - Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao 
      Saotome, Tsuyoshi Urushida, Hideki Katoh, Hideharu Hayashi, Division of 
      Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 
      Hamamatsu 431-3192, Japan.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - World J Cardiol
JT  - World journal of cardiology
JID - 101537090
PMC - PMC4110607
OTO - NOTNLM
OT  - Cardiac function
OT  - Cardiac magnetic resonance
OT  - Cardiomyopathy
OT  - Clinical features
OT  - Late gadolinium enhancement
OT  - Prognosis
EDAT- 2014/07/30 06:00
MHDA- 2014/07/30 06:01
PMCR- 2014/07/26
CRDT- 2014/07/29 06:00
PHST- 2013/12/20 00:00 [received]
PHST- 2014/03/21 00:00 [revised]
PHST- 2014/05/14 00:00 [accepted]
PHST- 2014/07/29 06:00 [entrez]
PHST- 2014/07/30 06:00 [pubmed]
PHST- 2014/07/30 06:01 [medline]
PHST- 2014/07/26 00:00 [pmc-release]
AID - 10.4330/wjc.v6.i7.585 [doi]
PST - ppublish
SO  - World J Cardiol. 2014 Jul 26;6(7):585-601. doi: 10.4330/wjc.v6.i7.585.